HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Tadayasu Okazaki Selected Research

5- (3- (4- (octadecyloxy)phenyl)propionylamino)- 2,4'- oxydibenzoic acid

7/2004A novel low molecular weight VEGF receptor-binding antagonist, VGA1102, inhibits the function of VEGF and in vivo tumor growth.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Tadayasu Okazaki Research Topics

Disease

1Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
07/2004
1Neoplasms (Cancer)
07/2004

Drug/Important Bio-Agent (IBA)

1LC 6IBA
07/2004
15- (3- (4- (octadecyloxy)phenyl)propionylamino)- 2,4'- oxydibenzoic acidIBA
07/2004
1Vascular Endothelial Growth Factor Receptors (VEGF Receptors)IBA
07/2004
1Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
07/2004